<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001224962</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>6</amendmentNo>
      <securitiesClassTitle>Common Stock, par value $0.0001 per share</securitiesClassTitle>
      <dateOfEvent>10/05/2026</dateOfEvent>
      <previouslyFiledFlag>false</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001808805</issuerCIK>
        <issuerCusips>
          <issuerCusipNumber>63909J108</issuerCusipNumber>
        </issuerCusips>
        <issuerName>Nautilus Biotechnology, Inc.</issuerName>
        <address>
          <street1 xmlns="http://www.sec.gov/edgar/common">2701 Eastlake Avenue East</street1>
          <city xmlns="http://www.sec.gov/edgar/common">Seattle</city>
          <stateOrCountry xmlns="http://www.sec.gov/edgar/common">WA</stateOrCountry>
          <zipCode xmlns="http://www.sec.gov/edgar/common">98102</zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Perceptive Advisors LLC</personName>
          <personPhoneNum>646-205-5345</personPhoneNum>
          <personAddress>
            <street1 xmlns="http://www.sec.gov/edgar/common">Alexander Rakitin, 51 Astor Place</street1>
            <street2 xmlns="http://www.sec.gov/edgar/common">10th Floor</street2>
            <city xmlns="http://www.sec.gov/edgar/common">New York</city>
            <stateOrCountry xmlns="http://www.sec.gov/edgar/common">NY</stateOrCountry>
            <zipCode xmlns="http://www.sec.gov/edgar/common">10003</zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0001224962</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Perceptive Advisors LLC</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>AF</fundType>
        <legalProceedings>Y</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0</soleVotingPower>
        <sharedVotingPower>4944512.00</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>4944512.00</sharedDispositivePower>
        <aggregateAmountOwned>4944512.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>3.9</percentOfClass>
        <typeOfReportingPerson>IA</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001164426</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Joseph Edelman</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>AF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>0</soleVotingPower>
        <sharedVotingPower>4944512.00</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>4944512.00</sharedDispositivePower>
        <aggregateAmountOwned>4944512.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>3.9</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001249675</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Perceptive Life Sciences Master Fund, Ltd.</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>E9</citizenshipOrOrganization>
        <soleVotingPower>0</soleVotingPower>
        <sharedVotingPower>4778652.00</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>4778652.00</sharedDispositivePower>
        <aggregateAmountOwned>4778652.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>3.8</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001890152</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>C2 Life Sciences LLC</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>E9</citizenshipOrOrganization>
        <soleVotingPower>0</soleVotingPower>
        <sharedVotingPower>165860</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>165860</sharedDispositivePower>
        <aggregateAmountOwned>165860</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>0.1</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Stock, par value $0.0001 per share</securityTitle>
        <issuerName>Nautilus Biotechnology, Inc.</issuerName>
        <issuerPrincipalAddress>
          <street1 xmlns="http://www.sec.gov/edgar/common">2701 Eastlake Avenue East</street1>
          <city xmlns="http://www.sec.gov/edgar/common">Seattle</city>
          <stateOrCountry xmlns="http://www.sec.gov/edgar/common">WA</stateOrCountry>
          <zipCode xmlns="http://www.sec.gov/edgar/common">98102</zipCode>
        </issuerPrincipalAddress>
      </item1>
      <item5>
        <percentageOfClassSecurities>Item 5 of the Schedule 13D is hereby amended and restated as follows:

The information set forth in rows 11 and 13 of the cover pages to this Schedule 13D is incorporated by reference. The percentages set forth in row 13 are based on 127,372,425 shares of Common Stock outstanding as of October 22, 2026, as disclosed by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on October 27, 2026.</percentageOfClassSecurities>
        <numberOfShares>The information set forth in rows 7 through 10 of the cover pages to this Schedule 13D is incorporated by reference. Neither Perceptive Advisors LLC ("Perceptive Advisors") nor Joseph Edelman ("Mr. Edelman") directly holds any Common Stock. Perceptive Life Sciences Master Fund, Ltd. (the "Master Fund") directly holds 4,778,652 shares of Common Stock, and C2 Life Sciences LLC ("C2") directly holds 165,860 shares of Common Stock. Perceptive Advisors serves as the investment manager to the Master Fund and C2. Mr. Edelman is the managing member of Perceptive Advisors.</numberOfShares>
        <transactionDesc>Except as set forth on Schedule A attached hereto as Exhibit 99.1 and incorporated herein by reference, the Reporting Persons have not effected any transactions in the Common Stock since the filing of Amendment No. 5 to this Schedule 13D. All transactions set forth on Schedule A were effected in the open market through brokers.</transactionDesc>
        <date5PercentOwnership>On October 16, 2026, the Reporting Persons ceased to be the beneficial owners of more than five percent of the Common Stock.</date5PercentOwnership>
      </item5>
      <item7>
        <filedExhibits>Exhibit 99.1 - Schedule A - Transactions in the Common Stock</filedExhibits>
      </item7>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Perceptive Advisors LLC</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Joseph Edelman</signature>
          <title>Joseph Edelman, Managing Member</title>
          <date>11/03/2026</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Joseph Edelman</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Joseph Edelman</signature>
          <title>Joseph Edelman</title>
          <date>11/03/2026</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Perceptive Life Sciences Master Fund, Ltd.</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Joseph Edelman</signature>
          <title>Joseph Edelman, Managing Member</title>
          <date>11/03/2026</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>C2 Life Sciences LLC</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Joseph Edelman</signature>
          <title>Joseph Edelman, Managing Member</title>
          <date>11/03/2026</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>

</edgarSubmission>
